The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
Khan, A. K. A., Piris, J., & Truelove, S. C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90831-5 · Cited by 814
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
PEPPERCORN, M. A., & GOLDMAN, P. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29238-2 · Cited by 450
SVARTZ, N. (1942) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1942.tb06841.x · Cited by 364
Absorption, metabolism, and excretion of salicylazosulfapyridine in man
Schröder, H., & Campbell, D. E. S. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1972134539 · Cited by 323
Klotz, U., Maier, K., Fischer, C., & Heinkel, K. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012253032602 · Cited by 322
Self-citationNational Cooperative Crohn's Disease Study: Adverse reactions to study drugs
Singleton, J. W., Law, D. H., Kelley, M. L., Mekhjian, H. S., & Sturdevant, R. A. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90386-x · Cited by 263
TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
Campieri, M., Lanfranchi, G. A., Bazzocchi, G., Franzin, G., Brignola, C., Battocchia, A., Sarti, F., Labo, G., & Dal Monte, P. R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90523-7 · Cited by 245
Distribution Studies of Salicylazosulfapyridine and its Metabolites
Peppercorn, M. A., & Goldman, P. (1973) · Gastroenterology · doi:10.1016/s0016-5085(73)80035-6 · Cited by 244
Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development
PEPPERCORN, M. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-377 · Cited by 241
Sulfasalazine: Adverse effects and desensitization
Taffet, S. L., & Das, K. M. (1983) · Digestive Diseases and Sciences · doi:10.1007/bf01296907 · Cited by 238
Cited by
Lindenberg, M., Kopp, S., & Dressman, J. B. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.001 · Cited by 864
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
New oral delivery systems for treatment of inflammatory bowel disease
Friend, D. R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.08.011 · Cited by 306
Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 291
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Metadata
- Authors
- Klotz, U.
- Venue
- Clinical Pharmacokinetics
- Published
- 1985
- Volume
- 10
- Issue
- 4
- Pages
- 285-302
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W2017167069
- Cited by
- 277
- References
- 36
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid. https://app.cochat.ai/papers/10.2165/00003088-198510040-00001
- The paper
- Klotz, U. (1985). Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-198510040-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.